Sofia, Bulgaria, July 3, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 2, 2025 the Company sold 518 619  (five  hundred eighteen thousand six hundred and eighteen) repurchased own shares representing 0.29% of the share capital of the Company, at a total value of BGN 3 640 994.86 on the Bulgarian Stock Exchange, the average price per share was BGN 7.02.

Sofia, Bulgaria, July 2, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on July 1, 2025 the Company sold 500 (five hundred) repurchased own shares representing 0.0003% of the share capital of the Company, at a total value of BGN 3 600.00 on the Bulgarian Stock Exchange, the average price per share was BGN 7.20.

Sofia, Bulgaria, June 30, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 27, 2025 the Company sold 6 000 (six thousand) repurchased own shares representing 0.003% of the share capital of the Company, at a total value of BGN 39 760.00 on the Bulgarian Stock Exchange, the average price per share was BGN 6.63.

София, Болгария, 27 июня 2025 года – В соответствии с требованиями ст. 115в, абз. 4, из ЗППЦБ “Софарма“ АД (SFA:„БФБ – София“, SPH: Warsaw Stock Exchange), уведомляет для решении Очередного общего собрания акционеров „Софарма“ АД,  состоялось 27.06.2025 г., касательно виду и размеру дивидендов за 2024 год, а также порядки и условий выплаты:

Общее собрание акционеров приняло предложение Совета директоров для выплате акционерам валовых дивидендов в размере 0,08 лева /восемь стотинок/ за акцию.

Sofia, Bulgaria, June 26, 2025 – According to the requirements of art. 17 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council, “Sopharma” AD (SFA: Bulgarian Stock Exchange, SPH: Warsaw Stock Exchange) notifies that on June 26, 2025 the Company sold 3 511 700 (three million five hundred eleven thousand seven hundred) repurchased own shares representing 1.95% of the share capital of the Company, at a total value of BGN 22 966 639.00 on the Bulgarian Stock Exchange, the average price per share was BGN 6.54.